June 9, 2014

A recently approved drug might make infusions for hemophiliacs fewer and further between. The Food and Drug Administration approved Biogen Idec's Eloctate, which clinical trials have shown works to treat bleeding episodes and to increase the time between prophylactic blood infusions for those with hemophilia A.

May 12, 2014

Bayer HealthCare on Monday announced that the Food and Drug Administration approved the company's new indication for Bayer's Kogenate FS antihemophilic factor VIII (recombinant) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults with hemophilia A.

January 13, 2014

Diplomat has acquired a hemophilia-focused specialty pharmacy based in Connecticut, the specialty pharmacy company said Monday.

December 23, 2013

Two experimental drugs under development by Biogen Idec are effective in reducing bleeding episodes in patients with two forms of hemophilia when administered as a preventive treatment, while also reducing the need for frequent injections, according to late-stage clinical trial data.

December 23, 2013

The Food and Drug Administration has approved a new treatment made by Danish drug maker Novo Nordiskfor a rare, genetic bleeding disorder, the agency said Monday.

October 24, 2013

A mobile app described as the specialty pharmacy industry's first for patients with hemophilia has become available.

October 17, 2013

The Food and Drug Administration has approved a new drug made by Novo Nordisk for treating hemophilia A, the Danish drug maker said.

June 27, 2013

The Food and Drug Administration has approved what's being called the first therapy of its kind to prevent bleeding episodes.

January 7, 2013

Biogen Idec is seeking Food and Drug Administration approval for a hemophilia drug that it called the first of its kind.

November 28, 2012

Novo Nordisk has launched a mobile app for hemophilia patients, the drug maker said.

July 9, 2012

Specialty pharmacy provider BioRx has acquired another specialty pharmacy provider based in Minnesota, BioRx said Monday.

May 29, 2012

BioPlus Specialty Pharmacy has appointed a new person to head its bleeding disorders program, the company said Tuesday.

January 12, 2012

Drug maker Octapharma USA has appointed David Holliday as VP commercial development, the company said.

April 28, 2011

Bayer HealthCare Pharmaceuticals and the World Federation of Hemophilia announced Thursday a three-year extension of Bayer’s sponsorship agreement with the WFH.

April 26, 2011

The Food and Drug Administration has approved a new storage option for a hemophilia A treatment made by Bayer HealthCare Pharmaceuticals, the drug maker said.

April 8, 2011

Danish drug maker Novo Nordisk has received the Corporate Leadership Award from the National Hemophilia Foundation in response to its research and development efforts for the disease, the company said Friday.

March 21, 2011

Patients with bleeding disorders could be eligible for a scholarship from a specialty pharmacy provider that specializes in treating them.

February 24, 2011

Novo Nordisk has filed for approval of a treatment for a rare genetic bleeding disorder, the Danish drug maker said Wednesday.

October 31, 2010

The U.S. subsidiary of a Swiss biotech company has started a late-stage trial of a...

August 15, 2010

The Food and Drug Administration has approved a prefilled dual-chamber syringe made by Pfizer for...

August 10, 2010

The Food and Drug Administration has approved a new dose of a treatment for hemophilia...

June 27, 2010

Bayer HealthCare Pharmaceuticals has launched a free mobile application for patients with hemophilia, the drug...

January 24, 2010

Bayer Schering Pharma will halt a mid-stage clinical trial of an investigational treatment for hemophilia,...

January 20, 2010

Despite its rarity, occurring in 1-in-5,000 to 1-in-25,000 male births, hemophilia can be a debilitating...